Cerevel Therapeutics Holdings Inc (CERE)
42.16
-0.14
(-0.33%)
USD |
NASDAQ |
May 10, 16:00
42.16
0.00 (0.00%)
After-Hours: 20:00
Cerevel Therapeutics Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
AbbVie Inc | 9.242 |
Immunogen Inc (DELISTED) | 0.1284 |
Bristol-Myers Squibb Co | 3.376 |
Madrigal Pharmaceuticals Inc | -- |
Adverum Biotechnologies Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.127B |
Total Liabilities (Quarterly) | 562.89M |
Shareholders Equity (Quarterly) | 564.46M |